Literature DB >> 24552829

Spatial and temporal stability of paneth cell phenotypes in Crohn's disease: implications for prognostic cellular biomarker development.

Ta-Chiang Liu1, Feng Gao, Dermot P B McGovern, Thaddeus S Stappenbeck.   

Abstract

BACKGROUND: We previously demonstrated that morphologic defects of ileal Paneth cells correlate with multiple susceptible genetic variants, the presence of granuloma, and clinical outcome in Crohn's disease. These studies were performed using uninvolved areas of resection specimens. To develop Paneth cell phenotype as a prognostic biomarker in Crohn's disease, further characterization is necessary. Specifically, effects of disease activity, phenotype duration, and the minimal crypt number that would allow for accurate Paneth cell phenotyping are unknown.
METHODS: We compared Paneth cell phenotypes in (1) 46 cases with paired involved and uninvolved sections; (2) 36 cases with multiple ileal resections over time; (3) "virtual biopsies" by randomly selecting 10 to 60 crypts from 85 surgical cases where 250 crypts had been analyzed; and (4) 26 cases with resection and biopsy performed within 1 year.
RESULTS: In paired resection specimens, the Paneth cell phenotypes in the uninvolved areas correlated with those seen in involved areas (P < 0.0001) and also predicted the presence of granuloma (P = 0.042). Importantly, the Paneth cell phenotype remained stable over time (P < 0.0001). By mathematical analyses, a minimum of 40 crypts was required to generate results equivalent to those using resection specimens. Finally, there was good correlation in Paneth cell phenotypes in biopsy specimens and resection specimens obtained within 1 year (P = 0.0004).
CONCLUSIONS: Accurate Paneth cell phenotypes can be assessed using biopsy materials with the caveat that sufficient well-oriented crypts exist in the specimen. This advance will extend the potential clinical application of this novel stratification platform.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24552829      PMCID: PMC4180521          DOI: 10.1097/01.MIB.0000442838.21040.d7

Source DB:  PubMed          Journal:  Inflamm Bowel Dis        ISSN: 1078-0998            Impact factor:   5.325


  15 in total

1.  Metagenomics and personalized medicine.

Authors:  Herbert W Virgin; John A Todd
Journal:  Cell       Date:  2011-09-30       Impact factor: 41.582

2.  Association of the T300A non-synonymous variant of the ATG16L1 gene with susceptibility to paediatric Crohn's disease.

Authors:  Robert N Baldassano; Jonathan P Bradfield; Dimitri S Monos; Cecilia E Kim; Joseph T Glessner; Tracy Casalunovo; Edward C Frackelton; F George Otieno; Stathis Kanterakis; Julie L Shaner; Ryan M Smith; Andrew W Eckert; Luke J Robinson; Chioma C Onyiah; Debra J Abrams; Rosetta M Chiavacci; Robert Skraban; Marcella Devoto; Struan F A Grant; Hakon Hakonarson
Journal:  Gut       Date:  2007-08       Impact factor: 23.059

3.  Genetic variants synthesize to produce paneth cell phenotypes that define subtypes of Crohn's disease.

Authors:  Kelli L VanDussen; Ta-Chiang Liu; Dalin Li; Fadi Towfic; Nir Modiano; Rachel Winter; Talin Haritunians; Kent D Taylor; Deepti Dhall; Stephan R Targan; Ramnik J Xavier; Dermot P B McGovern; Thaddeus S Stappenbeck
Journal:  Gastroenterology       Date:  2013-09-25       Impact factor: 22.682

4.  Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease.

Authors:  J P Hugot; M Chamaillard; H Zouali; S Lesage; J P Cézard; J Belaiche; S Almer; C Tysk; C A O'Morain; M Gassull; V Binder; Y Finkel; A Cortot; R Modigliani; P Laurent-Puig; C Gower-Rousseau; J Macry; J F Colombel; M Sahbatou; G Thomas
Journal:  Nature       Date:  2001-05-31       Impact factor: 49.962

5.  A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease.

Authors:  Y Ogura; D K Bonen; N Inohara; D L Nicolae; F F Chen; R Ramos; H Britton; T Moran; R Karaliuskas; R H Duerr; J P Achkar; S R Brant; T M Bayless; B S Kirschner; S B Hanauer; G Nuñez; J H Cho
Journal:  Nature       Date:  2001-05-31       Impact factor: 49.962

6.  Human β-defensin 3 peptide is increased and redistributed in Crohn's ileitis.

Authors:  Jeffrey P Meisch; Michiko Nishimura; Ryan M Vogel; Hannah C Sung; Beth A Bednarchik; Santosh K Ghosh; Pingfu Fu; Thomas McCormick; Aaron Weinberg; Alan D Levine
Journal:  Inflamm Bowel Dis       Date:  2013-04       Impact factor: 5.325

7.  Association between insertion mutation in NOD2 gene and Crohn's disease in German and British populations.

Authors:  J Hampe; A Cuthbert; P J Croucher; M M Mirza; S Mascheretti; S Fisher; H Frenzel; K King; A Hasselmeyer; A J MacPherson; S Bridger; S van Deventer; A Forbes; S Nikolaus; J E Lennard-Jones; U R Foelsch; M Krawczak; C Lewis; S Schreiber; C G Mathew
Journal:  Lancet       Date:  2001-06-16       Impact factor: 79.321

8.  Caspase-8 regulates TNF-α-induced epithelial necroptosis and terminal ileitis.

Authors:  Claudia Günther; Eva Martini; Nadine Wittkopf; Kerstin Amann; Benno Weigmann; Helmut Neumann; Maximilian J Waldner; Stephen M Hedrick; Stefan Tenzer; Markus F Neurath; Christoph Becker
Journal:  Nature       Date:  2011-09-14       Impact factor: 49.962

9.  Host-microbe interactions have shaped the genetic architecture of inflammatory bowel disease.

Authors:  Luke Jostins; Stephan Ripke; Rinse K Weersma; Richard H Duerr; Dermot P McGovern; Ken Y Hui; James C Lee; L Philip Schumm; Yashoda Sharma; Carl A Anderson; Jonah Essers; Mitja Mitrovic; Kaida Ning; Isabelle Cleynen; Emilie Theatre; Sarah L Spain; Soumya Raychaudhuri; Philippe Goyette; Zhi Wei; Clara Abraham; Jean-Paul Achkar; Tariq Ahmad; Leila Amininejad; Ashwin N Ananthakrishnan; Vibeke Andersen; Jane M Andrews; Leonard Baidoo; Tobias Balschun; Peter A Bampton; Alain Bitton; Gabrielle Boucher; Stephan Brand; Carsten Büning; Ariella Cohain; Sven Cichon; Mauro D'Amato; Dirk De Jong; Kathy L Devaney; Marla Dubinsky; Cathryn Edwards; David Ellinghaus; Lynnette R Ferguson; Denis Franchimont; Karin Fransen; Richard Gearry; Michel Georges; Christian Gieger; Jürgen Glas; Talin Haritunians; Ailsa Hart; Chris Hawkey; Matija Hedl; Xinli Hu; Tom H Karlsen; Limas Kupcinskas; Subra Kugathasan; Anna Latiano; Debby Laukens; Ian C Lawrance; Charlie W Lees; Edouard Louis; Gillian Mahy; John Mansfield; Angharad R Morgan; Craig Mowat; William Newman; Orazio Palmieri; Cyriel Y Ponsioen; Uros Potocnik; Natalie J Prescott; Miguel Regueiro; Jerome I Rotter; Richard K Russell; Jeremy D Sanderson; Miquel Sans; Jack Satsangi; Stefan Schreiber; Lisa A Simms; Jurgita Sventoraityte; Stephan R Targan; Kent D Taylor; Mark Tremelling; Hein W Verspaget; Martine De Vos; Cisca Wijmenga; David C Wilson; Juliane Winkelmann; Ramnik J Xavier; Sebastian Zeissig; Bin Zhang; Clarence K Zhang; Hongyu Zhao; Mark S Silverberg; Vito Annese; Hakon Hakonarson; Steven R Brant; Graham Radford-Smith; Christopher G Mathew; John D Rioux; Eric E Schadt; Mark J Daly; Andre Franke; Miles Parkes; Severine Vermeire; Jeffrey C Barrett; Judy H Cho
Journal:  Nature       Date:  2012-11-01       Impact factor: 49.962

10.  Identification of benzimidazole diamides as selective inhibitors of the nucleotide-binding oligomerization domain 2 (NOD2) signaling pathway.

Authors:  David J Rickard; Clark A Sehon; Viera Kasparcova; Lorena A Kallal; Xin Zeng; Monica N Montoute; Tushar Chordia; Derek D Poore; Hu Li; Zining Wu; Patrick M Eidam; Pamela A Haile; Jong Yu; John G Emery; Robert W Marquis; Peter J Gough; John Bertin
Journal:  PLoS One       Date:  2013-08-01       Impact factor: 3.240

View more
  13 in total

1.  LRRK2 but not ATG16L1 is associated with Paneth cell defect in Japanese Crohn's disease patients.

Authors:  Ta-Chiang Liu; Takeo Naito; Zhenqiu Liu; Kelli L VanDussen; Talin Haritunians; Dalin Li; Katsuya Endo; Yosuke Kawai; Masao Nagasaki; Yoshitaka Kinouchi; Dermot Pb McGovern; Tooru Shimosegawa; Yoichi Kakuta; Thaddeus S Stappenbeck
Journal:  JCI Insight       Date:  2017-03-23

2.  Interaction between smoking and ATG16L1T300A triggers Paneth cell defects in Crohn's disease.

Authors:  Ta-Chiang Liu; Justin T Kern; Kelli L VanDussen; Shanshan Xiong; Gerard E Kaiko; Craig B Wilen; Michael W Rajala; Roberta Caruso; Michael J Holtzman; Feng Gao; Dermot Pb McGovern; Gabriel Nunez; Richard D Head; Thaddeus S Stappenbeck
Journal:  J Clin Invest       Date:  2018-10-15       Impact factor: 14.808

3.  Paneth Cell Alterations in the Development and Phenotype of Crohn's Disease.

Authors:  Thaddeus S Stappenbeck; Dermot P B McGovern
Journal:  Gastroenterology       Date:  2016-10-08       Impact factor: 22.682

4.  Posttranscriptional regulation of colonic epithelial repair by RNA binding protein IMP1/IGF2BP1.

Authors:  Priya Chatterji; Patrick A Williams; Kelly A Whelan; Fernando C Samper; Sarah F Andres; Lauren A Simon; Louis R Parham; Rei Mizuno; Emma T Lundsmith; David Sm Lee; Shun Liang; Hr Sagara Wijeratne; Stefanie Marti; Lillian Chau; Veronique Giroux; Benjamin J Wilkins; Gary D Wu; Premal Shah; Gian G Tartaglia; Kathryn E Hamilton
Journal:  EMBO Rep       Date:  2019-05-06       Impact factor: 8.807

Review 5.  Mitochondria and Inflammatory Bowel Diseases: Toward a Stratified Therapeutic Intervention.

Authors:  Gwo-Tzer Ho; Arianne L Theiss
Journal:  Annu Rev Physiol       Date:  2021-10-06       Impact factor: 19.318

6.  The γδ IEL effector API5 masks genetic susceptibility to Paneth cell death.

Authors:  Yu Matsuzawa-Ishimoto; Xiaomin Yao; Akiko Koide; Beatrix M Ueberheide; Jordan E Axelrad; Bernardo S Reis; Roham Parsa; Jessica A Neil; Joseph C Devlin; Eugene Rudensky; M Zahidunnabi Dewan; Michael Cammer; Richard S Blumberg; Yi Ding; Kelly V Ruggles; Daniel Mucida; Shohei Koide; Ken Cadwell
Journal:  Nature       Date:  2022-10-05       Impact factor: 69.504

Review 7.  Implications of Paneth cell dysfunction on gastrointestinal health and disease.

Authors:  Vivian H Lee; Ajay S Gulati
Journal:  Curr Opin Gastroenterol       Date:  2022-09-24       Impact factor: 2.741

8.  Paneth cell defects in Crohn's disease patients promote dysbiosis.

Authors:  Ta-Chiang Liu; Bhaskar Gurram; Megan T Baldridge; Richard Head; Vy Lam; Chengwei Luo; Yumei Cao; Pippa Simpson; Michael Hayward; Mary L Holtz; Pavlos Bousounis; Joshua Noe; Diana Lerner; Jose Cabrera; Vincent Biank; Michael Stephens; Curtis Huttenhower; Dermot Pb McGovern; Ramnik J Xavier; Thaddeus S Stappenbeck; Nita H Salzman
Journal:  JCI Insight       Date:  2016-06-02

9.  Western diet induces Paneth cell defects through microbiome alterations and farnesoid X receptor and type I interferon activation.

Authors:  Ta-Chiang Liu; Justin T Kern; Umang Jain; Naomi M Sonnek; Shanshan Xiong; Katherine F Simpson; Kelli L VanDussen; Emma S Winkler; Talin Haritunians; Atika Malique; Qiuhe Lu; Yo Sasaki; Chad Storer; Michael S Diamond; Richard D Head; Dermot P B McGovern; Thaddeus S Stappenbeck
Journal:  Cell Host Microbe       Date:  2021-05-18       Impact factor: 31.316

10.  Targeting Mitochondrial Damage as a Therapeutic for Ileal Crohn's Disease.

Authors:  Kibrom M Alula; Dakota N Jackson; Andrew D Smith; Daniel S Kim; Kevin Turner; Elizabeth Odstrcil; Benny A Kaipparettu; Themistocles Dassopoulos; K Venuprasad; Linda A Feagins; Arianne L Theiss
Journal:  Cells       Date:  2021-05-29       Impact factor: 6.600

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.